艾司妥单抗
Anti-Human IGF1RxHer3 Bispecific Antibody (Istiratumab; MM 141; MM-005)
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
Quantity
- +
Product Overview
Product Name Anti-Human IGF1RxHer3 Bispecific Antibody (Istiratumab; MM 141; MM-005)
CAS1509928-04-4
Security information
Product details

Istiratumab, a bispecific mAb against IGF-1R and ErbB3, promotes receptor degradation via proteasomes, inhibiting AKT in pancreatic cancer cells and blocking PI3K/MAPK in ovarian cancer. It enhances chemo efficacy, potentiating paclitaxel, cisplatin, and doxorubicin in preclinical studies.

Related
Sorry, no related items
History
Vesencumab (Anti-NRP1 / VEGF165R / CD304)
Flanvotumab (Anti-TRP1 / TYRP1)
Anti-Human IGF1RxHer3 Bispecific Antibody (Istiratumab; MM 141; MM-005)
Becotatug | JMT-101
Anifrolumab (Anti-IFNAR1)
Ozoralizumab
D-Pinitol (Synonyms: 3-O-Methyl-D-chiro-inositol; Methylinositol; D-(+)-Pinitol; Inzitol;(1R,2S,3R,4S,5S,6S)-6-Methoxycyclohexane-1,2,3,4,5-pentaol)
Bevacizumab (anti-VEGF) | RhuMab VEGF
Ramucirumab; LY3009806; IMC-1121B